Cevostamab Biosimilar (Anti- FcRH5 / IRTA2 / CD307e Reference Antibody)

SKU: orb2703685

Description

Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells.

Images & Validation

−

Key Properties

−

Antibody Type	Biosimilar Antibody
Clonality	Monoclonal
Target	Cevostamab Biosimilar(Anti- FcRH5 / IRTA2 / CD307e Reference Antibody)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Cevostamab Biosimilar(Anti- FcRH5 / IRTA2 / CD307e Reference Antibody)

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols